Direct‐acting antiviral agents for liver transplant recipients with recurrent genotype 1 hepatitis C virus infection: Systematic review and meta‐analysis

BACKGROUND: Comprehensive evaluation of safety and efficacy of different combinations of direct‐acting antivirals (DAAs) in liver transplant recipients with genotype 1 (GT1) hepatitis C virus (HCV) recurrence remains limited. Therefore, we performed this systematic review and meta‐analysis in order...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jiaye, Ma, Buyun, Cao, Wanlu, Li, Meng, Bramer, Wichor M., Peppelenbosch, Maikel P., Pan, Qiuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850617/
https://www.ncbi.nlm.nih.gov/pubmed/30615227
http://dx.doi.org/10.1111/tid.13047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850617/
https://www.ncbi.nlm.nih.gov/pubmed/30615227
http://dx.doi.org/10.1111/tid.13047

Ejemplares similares